<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Anti Anginal Drugs</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Anti Anginal Drugs</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                22 Questions | 22 Total Marks | 32 min Duration | ~87.27 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 22 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 32 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 22</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Anti Anginal Drugs - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 22</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 22 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following drugs can cause drug-induced lupus syndrome?", "options": [{"label": "A", "text": "Procainamide", "correct": true}, {"label": "B", "text": "Lignocaine", "correct": false}, {"label": "C", "text": "Esmolol", "correct": false}, {"label": "D", "text": "Flecainide", "correct": false}], "correct_answer": "A. Procainamide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Procainamide Procainamide class IA drug which causes drug-induced lupus syndrome Procainamide-induced lupus syndrome</p>\n<p><strong>Highyeild:</strong></p><p>In individuals who are ‚Äúslow acetylators,‚Äù the procainamide-induced lupus syndrome develops more often and earlier during treatment than among rapid acetylators. it is more common in slow acetylators than in rapid acetylators. Drugs causing side effects: INH Hydralazine Minocycline Methyldopa Chlorpromazine Quinidine Procainamide</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. LIGNOCAINE The main toxicity is dose-related neurological effects: Drowsiness, nausea, paresthesias, blurred vision, disorientation, nystagmus, twitchings, and fits. Lidocaine has practically no proarrhythmic potential and is the least cardiotoxic antiarrhythmic. Only excessive doses cause cardiac depression and hypotension. Option: C. ESMOLOL IS NOT ASSOCIATED WITH DRUG-INDUCED LUPUS SYNDROME. Option: D. FLECAINIDE IS NOT ASSOCIATED WITH DRUG-INDUCED LUPUS SYNDROME. It is reserved for resistant cases of paroxysmal AF and life-threatening sustained VT in patients not having associated CHF.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is correct about cinchonism caused by Quinidine?", "options": [{"label": "A", "text": "It includes headache and tinnitus", "correct": false}, {"label": "B", "text": "Cinchonism is related to plasma Quinidine concentration", "correct": false}, {"label": "C", "text": "Cinchonism can be managed by dose reduction", "correct": false}, {"label": "D", "text": "All of the above", "correct": true}], "correct_answer": "D. All of the above", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>All of the above</p>\n<p><strong>Highyeild:</strong></p><p>Quinidine: It also can produce cinchonism, a syndrome that includes headache and tinnitus Cinchonism usually is related to elevated plasma Quinidine concentrations and can be managed by dose reduction Cinchonism is a dose-dependent side effect of Quinidine</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. It includes headache and tinnitus Option: B . Cinchonism is related to plasma Quinidine concentration Option: C. Cinchonism can be managed by dose reduction note: all are correct statements.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "About adenosine, all are true except:", "options": [{"label": "A", "text": "Administered as a rapid intravenous bolus for the acute termination of re-entrant supraventricular arrhythmias", "correct": false}, {"label": "B", "text": "Used to produce controlled hypotension during some surgical procedures", "correct": false}, {"label": "C", "text": "Short-acting due to rapid uptake and inactivation", "correct": false}, {"label": "D", "text": "Can be given by peripheral veins while giving a bolus", "correct": true}], "correct_answer": "D. Can be given by peripheral veins while giving a bolus", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Can be given by peripheral veins while giving a bolus</p>\n<p><strong>Highyeild:</strong></p><p>Adenosine: Naturally occurring nucleoside MOA: Adenosine activates acetylcholine-sensitive K+ current in the atrium and sinus, and AV nodes, resulting in Shortening of APD Hyperpolarization Slowing of normal automaticity USE: Administered as a rapid intravenous bolus for the acute termination of re-entrant supraventricular arrhythmias, PSVT Used to produce controlled hypotension during some surgical procedures and in the diagnosis of coronary artery disease It is short-acting due to the rapid uptake and inactivation of adenosine deaminase inside the cells T1/2 = 10 seconds Preferably given by large central veins while giving bolus because if we give in the peripheral vein, it will get deactivated until it reaches the heart.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Administered as a rapid intravenous bolus for the acute termination of re-entrant supraventricular arrhythmias Option: B . Used to produce controlled hypotension during some surgical procedures Option: C . Short-acting due to rapid uptake and inactivation note: a, b, and c are true statements.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Following adverse effects are seen with adenosine except:", "options": [{"label": "A", "text": "Transient asystole", "correct": false}, {"label": "B", "text": "Chest fullness", "correct": false}, {"label": "C", "text": "Dry Cough", "correct": true}, {"label": "D", "text": "Dyspnea", "correct": false}], "correct_answer": "C. Dry Cough", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Dry Cough</p>\n<p><strong>Highyeild:</strong></p><p>Adenosine Contraindications/Precautions Poison/drug induced tachycardia is contraindicated 2nd and 3rd degree block is contraindicated Transient side effects; flushing, CP, asystole, brady, ectopy Less effective with theophylline or caffeine If used for VT may cause worsening of clinical condition Transient periods of sinus brady or ventricular ectopy common after termination of SVT Safe in pregnancy Adverse effects of adenosine: Adverse effects are short-lived because the drug is transported into cells and deaminated so rapidly</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Transient asystole is common but usually lasts less than 5 Option B and D. Most patients feel a sense of chest fullness and dyspnea when administering therapeutic doses (6 to 12 mg) of adenosine . DRY COUGH IS CAUSED BY ACE INHIBITORS.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The drug of choice in most of the cases of acute paroxysmal supraventricular tachycardia is:", "options": [{"label": "A", "text": "Adenosine", "correct": true}, {"label": "B", "text": "Amiodarone", "correct": false}, {"label": "C", "text": "Propranolol", "correct": false}, {"label": "D", "text": "Quinidine", "correct": false}], "correct_answer": "A. Adenosine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Adenosine</p>\n<p><strong>Highyeild:</strong></p><p>In most cases, acute paroxysmal supraventricular tachycardia is Adenosine because this arrhythmia lasts for a few minutes. So, we want a drug that acts faster and has short-duration action. Adenosine is short-acting due to the rapid uptake and inactivation of adenosine by deaminase inside the cells. T1/2 = 10 seconds Preferably given by large central veins while giving bolus because if we give in a peripheral vein, it will get deactivated until it reaches the heart.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B, C. verapamil/diltiazem/esmolol Oral verapamil/diltiazem/propranolol/sotalol are also used in PSVT, BUT HERE QUESTION IS REGARDING DOC. Option: D. QUINIDINE is effective in many atrial and ventricular arrhythmias, it is seldom used now because of the risk of adverse effects, including that of torsades de pointes, sudden cardiac arrest, or VF</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is incorrect about Isosorbide Mononitrate?", "options": [{"label": "A", "text": "An active metabolite of isosorbide dinitrate", "correct": false}, {"label": "B", "text": "Undergoes high first-pass metabolism when given orally", "correct": true}, {"label": "C", "text": "Not used sublingually", "correct": false}, {"label": "D", "text": "Longer acting formulation is used for prophylaxis of angina", "correct": false}], "correct_answer": "B. Undergoes high first-pass metabolism when given orally", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Undergoes high first-pass metabolism when given orally</p>\n<p><strong>Highyeild:</strong></p><p>Isosorbide mononitrate: An active metabolite of isosorbide dinitrate When given orally, it undergoes little first-pass metabolism Bioavailability is high Not used sublingual Interindividual differences are minimal The longer-acting formulation is used for prophylaxis of angina NOTE: All Nitrates except isosorbide mononitrate undergo extensive and variable first-pass metabolism in the liver.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. An active metabolite of isosorbide dinitrate Option: C. Not used sublingual Option: D. The longer-acting formulation is used for prophylaxis of angina note: all are true statements.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Longest acting nitrate among the following is:", "options": [{"label": "A", "text": "Glyceryl trinitrate", "correct": false}, {"label": "B", "text": "Amyl nitrite", "correct": false}, {"label": "C", "text": "Isosorbide di nitrate (SUBLINGUAL)", "correct": false}, {"label": "D", "text": "Penta erythritol tetra nitrate", "correct": true}], "correct_answer": "D. Penta erythritol tetra nitrate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Penta erythritol tetra nitrate Penta erythritol tetra nitrate is the longest acting, and Amyl nitrite is the shortest acting among the nitrate group</p>\n<p><strong>Highyeild:</strong></p><p>Erythrityl tetranitrate and pentaerythritol tetranitrate These are longer-acting nitrates used only for chronic prophylaxis. Sustained release oral preparations are now available for dosing 2‚Äì3 times daily. There has been considerable skepticism about the efficacy of long-acting nitrates orally administered. Studies with high doses have shown that first-pass metabolism in the liver can be saturated and haemodynamic effects lasting 4‚Äì6 hours do occur.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Options A, B, and C- short-acting nitrates</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following options, the important action of nitrates in angina is:", "options": [{"label": "A", "text": "Coronary vasodilation", "correct": false}, {"label": "B", "text": "Decreases preload", "correct": true}, {"label": "C", "text": "Decreases afterload", "correct": false}, {"label": "D", "text": "Decreases heart rate", "correct": false}], "correct_answer": "B. Decreases preload", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Decreases preload</p>\n<p><strong>Highyeild:</strong></p><p>In stable angina, the primary mechanism of nitrates is to reduce the workload on the heart by reducing preload and, at higher concentrations, reducing after-load. The primary mechanism in Prinzmetal angina by nitrates is endothelium-independent coronary vasodilatation. The relaxant effect on larger coronary vessels is the principal action of nitrates benefiting variant angina by counteracting coronary spasm. In classical angina, the primary effect is to reduce cardiac work by action on peripheral vasculature, though increased blood supply to the ischaemic area may contribute. Exercise tolerance of angina patients is improved because the same amount of exercise causes lesser augmentation of cardiac work.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A . Coronary vasodilation Option: C. Decreases afterload Option: D. Decreases heart rate note: a,c, and d are the wrong statements.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following Pharmacodynamic features are seen with nitrates?", "options": [{"label": "A", "text": "Tolerance", "correct": false}, {"label": "B", "text": "Cross tolerance", "correct": false}, {"label": "C", "text": "Dependence", "correct": false}, {"label": "D", "text": "All of the above", "correct": true}], "correct_answer": "D. All of the above", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>All of the above</p>\n<p><strong>Highyeild:</strong></p><p>Classification Coronary vasodilators Nitrites & nitrates according to duration of action Shot acting (3 to 60 min) Amyl nitrite, nitroglycerin (sublingual), isosorbide dinitrate Intermediate acting(3 to 6hrs) Isosorbide dinitrate,nitroglycerin (ointment) Long acting(6 to 10 hrs) Erythirtyl tetranitrate, nitroglycerin (trans-cutaneous</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Tolerance: Tolerance develops on continuous usage of nitrates because of the generation of reactive oxygen species, which inhibits nitrate activating enzyme mitochondrial aldehyde dehydrogenase Option: B. Cross tolerance: Seen among all nitrates Option: C. Dependence: Continuous usage leads to dependence, and Sudden withdrawal will result in spasms of coronary and peripheral blood vessels. MI and sudden deaths may occur</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The following are true about nitrate tolerance except:", "options": [{"label": "A", "text": "Cross tolerance occurs among nitrates", "correct": false}, {"label": "B", "text": "Tolerance is seen with intermittent use of sublingual GTN for attacks of angina", "correct": true}, {"label": "C", "text": "Tolerance develops when GTN is used transdermally", "correct": false}, {"label": "D", "text": "The reason for tolerance is the generation of reactive oxygen species", "correct": false}], "correct_answer": "B. Tolerance is seen with intermittent use of sublingual GTN for attacks of angina", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Tolerance is seen with intermittent use of sublingual GTN for attacks of angina Tolerance Tolerance develops on continuous usage of nitrates because of the generation of reactive oxygen species, which inhibits nitrate activating enzyme mitochondrial aldehyde dehydrogenase Tolerance to nitrates can be overcome by giving drug-free intervalsIntermittent use of sublingual GTN for attacks of angina will not produce tolerance Tolerance develops to GTN, when used orally, transdermally or by continuous i.v. Infusion round the clock and with long-acting agents (sustained release)Tolerance seen with higher dosesCross tolerance occurs among nitrates.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A person complains of a headache only when he starts his work on Monday, and the headache decreases on subsequent days of work. On weekends he will be fine, and only on Monday, he once again gets a headache. From the history, the person may be working in the following industry:", "options": [{"label": "A", "text": "Explosives", "correct": true}, {"label": "B", "text": "Software", "correct": false}, {"label": "C", "text": "Ceramic", "correct": false}, {"label": "D", "text": "Papermill", "correct": false}], "correct_answer": "A. Explosives", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Explosives</p>\n<p><strong>Highyeild:</strong></p><p>‚ÄúMonday disease‚Äù is seen among workers working in nitrate (the principal component of fertilizer and explosives) industries. When they are exposed to nitrates, they develop headaches after they come to work on Monday due to vasodilatation caused by nitrates. This is called Monday disease. After continuously working through the week, they develop tolerance to headaches, but the nitrate effect will be absent when they are on leave on Sunday. Once they come to work on Monday, they again develop headaches due to vasodilatation caused by nitrates.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Verapamil acts through blocking:", "options": [{"label": "A", "text": "L-type calcium channel", "correct": true}, {"label": "B", "text": "N-type calcium channel", "correct": false}, {"label": "C", "text": "T-type calcium channel", "correct": false}, {"label": "D", "text": "P/Q type calcium channel", "correct": false}], "correct_answer": "A. L-type calcium channel", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>L-type calcium channel L-type calcium channel, Nimodipine is a dihydropyridine L-type calcium channel blocker. Calcium channel blockers prevent calcium from entering cells in the heart and blood vessel walls and are often used to treat high blood pressure. Nimodipine acts on the CACNA1C calcium influx gene.</p>\n<p><strong>Highyeild:</strong></p><p>L-type calcium channel means long-lasting. Verapamil, Diltiazem, and dihydropyridines act by blocking L type calcium channels. The N-type of calcium channel is a neuronal calcium channel blocked by Gabapentin, and pregabalin. T type of calcium channel is a Transient calcium channel blocked by Flunarazine and Ethosuximide.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. N-type calcium channel- Many known N-type calcium channel blockers function to inhibit channel activity, although the most notable blockers are œâ-conotoxins . Option: C. T-type calcium channel- The co-administration of T-type calcium channel blockers with standard Parkinson